CeraVe Baby Diaper Rash Cream + Desitin Maximum Strength Original Paste

Pre-clinicalTerminated

0 watching 0 views this week💤 Quiet

Hype Score

Development Stage

Pre-clinical

Phase 1

Phase 2

Phase 3

Approved

Indication / Disease

Diaper Rash

Conditions

Diaper Rash

Trial Timeline

Dec 1, 2014 → Jul 1, 2016

NCT ID

NCT02299206

About CeraVe Baby Diaper Rash Cream + Desitin Maximum Strength Original Paste

CeraVe Baby Diaper Rash Cream + Desitin Maximum Strength Original Paste is a pre-clinical stage product being developed by Bausch Health for Diaper Rash. The current trial status is terminated. This product is registered under clinical trial identifier NCT02299206. Target conditions include Diaper Rash.

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (1)

NCT ID	Phase	Status	Start	Completion	Indication
NCT02299206	Pre-clinical	Terminated	Dec 1, 2014	Jul 1, 2016	Diaper Rash

Competing Products

1 competing product in Diaper Rash

See all competitors

Product	Company	Stage	Hype Score
0.25 % Miconazole Nitrate Ointment	GSK plc	Approved	84

Other Products from Bausch Health

nabiloneApproved

High dose budesonide rectal foam + Low dose budesonide rectal foam + Matching placebo rectal foamApproved

benzoyl peroxide wash + Tretinoin gelApproved

Adapalene Gel + Tretinoin GelApproved

Omeprazole/sodium bicarbonateApproved